NCT06949462 Effectiveness of Large Language Model for Anaesthesia and Procedural Consent
| NCT ID | NCT06949462 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore General Hospital |
| Condition | Consent Forms |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2026-04-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-01-07 with a primary completion date of 2026-04-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patient understanding of anaesthesia risks remains inconsistent due to time constraints, language barriers, and variable clinician communication styles. Traditional verbal consent may not consistently ensure comprehension or reduce preoperative anxiety. PEAR (Patient Education of Anesthesia Risks) is a multilingual, AI-driven chatbot developed to enhance patient education and improve the quality of anaesthesia risk counselling. Study Objective: To compare PEAR's performance in delivering anaesthesia risk consent against the standard face-to-face verbal method.
Eligibility Criteria
Inclusion Criteria: \- Adults (≥21 years old) undergoing elective surgery requiring anaesthesia Classified as ASA Physical Status I to III * Able to provide informed consent * Able to communicate effectively in English, Chinese (Mandarin), Malay, or Tamil * Willing and able to complete questionnaires and interact with the PEAR chatbot (intervention arm) Exclusion Criteria: * ASA Physical Status IV or above * Cognitive impairment or psychiatric conditions that may limit comprehension or communication * Non-literate patients or those unable to understand English, Chinese, Malay, or Tamil * Emergency surgery cases * Prior participation in the study (to prevent bias)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06949462 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 99 Years, studying Consent Forms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06949462 currently recruiting?
Yes, NCT06949462 is actively recruiting participants. Contact the research team at yuhe.ke36@gmail.com for enrollment information.
Where is the NCT06949462 trial being conducted?
This trial is being conducted at Singapore, Singapore, Singapore, Singapore.
Who is sponsoring the NCT06949462 clinical trial?
NCT06949462 is sponsored by Singapore General Hospital. The trial plans to enroll 120 participants.